Abstract
Use of an anti-IL-19 antibody for threating breast cancer, either alone or in combination iwth an anti-il-20 and/or anti-IL-20R1 antibody
Original language | English |
---|---|
Patent number | 8377441 |
Publication status | Published - 1800 |
Original language | English |
---|---|
Patent number | 8377441 |
Publication status | Published - 1800 |